Picture of Laboratorios Farmaceuticos Rovi logo

ROVI — Laboratorios Farmaceuticos Rovi News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Spanish stocks - Factors to watch on Dec 6

Dec 6 (Reuters) - The following Spanish stocks may be
affected by newspaper reports and other factors on Friday.
Reuters has not verified the newspaper reports, and cannot vouch
for their accuracy:
   
    PUIG  PUIGb.MC  
    Puig said on Thursday it was conducting a global withdrawal
of some batches of a spray from its Charlotte Tilbury brand,
pointing to quality issues.  urn:newsml:reuters.com:*:nFWN3N60G2
    
    ROVI  ROVI.MC  
    Rovi plans to hold a Capital Markets Day in the first half
of 2025 to focus on the long-term forecast for its third-party
manufacturing business and its Schizophrenia treatment Okedi,
Spanish newspaper Cinco Dias said on Friday citing unidentified
market sources.
    
    INDRA  IDR.MC  
    Madrid-based technology and defence company Escribano
Mechanical and Engineering increased its stake in Indra to 14.3%
from 8%, remaining its second biggest shareholder, newspaper
Expansion said on Friday.
    
    CELLNEX  CLNX.MC  
    Morgan Stanley raised its target price to 40 euros ($42.29
from 39 euros.  urn:newsml:reuters.com:*:nAZN2RHZ0R
    
    ENDESA  ELE.MC  
    Morgan Stanley raised its target price to 20.5 euros
($21.67) from 20 euros.  urn:newsml:reuters.com:*:nAZN2RHZ0P
    
    For today's European market outlook double click on  .EU . 
    For real-time moves on the Spanish blue-chip index IBEX
please double click on  .IBEX  
    For IBEX constituent stocks highlight .IBEX in the command
box and press the F3 button on your keyboard 
    For latest news on Spanish stock moves double click  HOT-ES 
    For Spanish language market report double click on  .MES 
    For latest Eurostocks report please double click on  .EU 


($1 = 0.9458 euros)

 (Gdansk Newsroom; Gdansk.newsroom@thomsonreuters.com
+48 58 769 66 00)

Recent news on Laboratorios Farmaceuticos Rovi

See all news